CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, R. I.
Right arrow Articles by Poole, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, R. I.
Right arrow Articles by Poole, L.

Canadian Journal of Anesthesia, Vol 38, 996-1004, Copyright © 1991 by Canadian Anesthesiologists' Society


ARTICLES

A comparison of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft surgery

RI Hall, JT Murphy, EA Moffitt, R Landymore, PT Pollak and L Poole
Department of Anaesthesia, Victoria General Hospital, Dalhousie University, Halifax, Nova Scotia, Canada.

The purpose of this study was to compare propofol-sufentanil with enflurane-sufentanil anaesthesia for patients undergoing elective coronary artery bypass graft (CABG) surgery with respect to changes in (1) haemodynamic variables; (2) myocardial blood flow and metabolism; (3) serum cortisol, triglyceride, lipoprotein concentrations and liver function; and (4) recovery characteristics. Forty-seven patients with preserved ventricular function (ejection fraction greater than 40%, left ventricular end diastolic pressure less than or equal to 16 mmHg) were studied. Patients in Group A (n = 24) received sufentanil 0.2 microgram.kg-1 and propofol 1-2 mg.kg-1 for induction of anaesthesia which was maintained with a variable rate propofol (50-200 micrograms.kg-1.min-1) infusion and supplemental sufentanil (maximum total 5 micrograms.kg-1). Patients in Group B (n = 23) received sufentanil 5 micrograms.kg-1 for induction of anaesthesia which was maintained with enflurane and supplemental sufentanil (maximum total 7 micrograms.kg-1). Haemodynamic and myocardial metabolic profiles were determined at the awake-sedated, post-induction, post-intubation, first skin incision, post-sternotomy, and pre-cardiopulmonary bypass intervals. Induction of anaesthesia produced a larger reduction in systolic blood pressure in Group A (156 +/- 22 to 104 +/- 20 mmHg vs 152 +/- 26 to 124 +/- 24 mmHg; P less than 0.05). No statistical differences were detected at any other time or in any other variable including myocardial lactate production (n = 13 events in each group), time to tracheal extubation and time to discharge from the ICU. We concluded that, apart from hypotension on induction of anaesthesia, propofol-sufentanil anaesthesia produced anaesthetic conditions equivalent to enflurane-sufentanil anaesthesia for CABG surgery.


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
C. H. Yu and W. S. Beattie
The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis: [Les effets des anesthesiques volatils sur les complications ischemiques et la mortalite cardiaques pendant le PAC : une meta-analyse].
Can J Anesth, September 1, 2006; 53(9): 906 - 918.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. A. Symons and P. S. Myles
Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis
Br. J. Anaesth., August 1, 2006; 97(2): 127 - 136.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. Hofland, I. Gultuna, and R. Tenbrinck
Xenon anaesthesia for laparoscopic cholecystectomy in a patient with Eisenmenger's syndrome{{dagger}}
Br. J. Anaesth., June 1, 2001; 86(6): 882 - 886.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. D. Williams, T. K. Jones, K. A. Hanson, and J. P. Morray
The Hemodynamic Effects of Propofol in Children with Congenital Heart Disease
Anesth. Analg., December 1, 1999; 89(6): 1411 - 1411.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
P. F. Wouters, M. Van de Velde, and J. Van Hemelrijck
Cardiovascular Effects of Propofol
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 121 - 131.
[PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. D. Swenson and P. L. Bailey
Opioids in Cardiovascular Anesthesia
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 146 - 163.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the Canadian Anesthesiologists' Society.